The Global Pharmacogenomics Market size is expected to reach $9.9 billion by 2025, rising at a market growth of 8.8% CAGR during the forecast period.
Pharmacogenomics or personalized medicine is defined as the tailoring of medical treatment to the specific characteristics of each patient. This concept, in reality, involves the ability to classify individuals into sub-populations which are disproportionately susceptible to a particular disease or responsive to a particular treatment. Personalized medicine emphasizes on the paradigm shift in medicine from reaction to prevention. The individual response to the drug varies according to the genetic composition. Most of the responses are positive and show improvement while few face the side effects. To address those variations, it is necessary to study how the drug processing is affected by the genes. So when the genetic variation is affecting the drug processing and response, there is the scope of the clinical study to be conducted and based on the result, adjust the dosage or to find a different drug according to the genetic composition of an individual.
Full Report: https://www.kbvresearch.com/pharmacogenomics-market/